• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和表征葫芦素,一种新型小分子肌球蛋白受体激酶 a 抑制剂。

Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a.

机构信息

School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China.

School of Laboratory Medicine, Chengdu Medical College, Chengdu, China.

出版信息

BMC Complement Altern Med. 2019 Nov 6;19(1):295. doi: 10.1186/s12906-019-2709-z.

DOI:10.1186/s12906-019-2709-z
PMID:31694615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6836411/
Abstract

BACKGROUND

NGF-TrkA is well known to play a key role in propagating and sustaining pruritogenic signals, which form the pathology of chronic pruritus. Inhibition of NGF-TrkA is a known strategy for the treatment of pruritus. In the present paper, we describe the identification, in vitro characterization, structure-activity analysis, and inhibitory evaluation of a novel TrkA inhibitory scaffold exemplified by Cucurbitacins (Cus).

METHODS

Cus were identified as TrkA inhibitors in a large-scale kinase library screen. To obtain structural models of Cus as TrkA inhibitors, AutoDock was used to explore their binding to TrkA. Furthermore, PC12 cell culture systems have been used to study the effects of Cus and traditional Chinese medicinal plants (Tian Gua Di and bitter gourd leaf) extracts on the kinase activity of TrkA.

RESULTS

Cus block the phosphorylation of TrkA on several tyrosine sites, including Tyr490, Tyr674/675, and Tyr785, and inhibit downstream Akt and MAPK phosphorylation in response to NGF in PC12 cell model systems. Furthermore, traditional Chinese medicinal plants (Tian Gua Di and bitter gourd leaf) containing Cu extracts were shown to inhibit the phosphorylation of TrkA and Akt. These data reveal mechanisms, at least partly, of the anti-pruritus bioactivity of Cus.

CONCLUSION

Taken together, with the recent discovery of the important role of TrkA as a therapeutic target, Cus could be the basis for the design of improved TrkA kinase inhibitors, which could someday help treat pruritus.

摘要

背景

神经生长因子-TrkA 已被证实可在慢性瘙痒症的病理过程中发挥关键作用,以传递和维持瘙痒信号。抑制 NGF-TrkA 是治疗瘙痒的一种已知策略。在本研究中,我们描述了葫芦素(Cus)的鉴定、体外特征分析、结构活性分析及其作为新型 TrkA 抑制剂的抑制评估。

方法

通过大规模激酶文库筛选发现 Cus 是 TrkA 的抑制剂。为了获得 Cus 作为 TrkA 抑制剂的结构模型,我们使用 AutoDock 来探索其与 TrkA 的结合。此外,还使用 PC12 细胞培养系统研究了 Cus 和传统中药(天花粉和苦瓜叶)提取物对 TrkA 激酶活性的影响。

结果

Cus 可阻断 TrkA 在几个酪氨酸残基上的磷酸化,包括 Tyr490、Tyr674/675 和 Tyr785,并抑制 PC12 细胞模型系统中 NGF 诱导的 Akt 和 MAPK 的磷酸化。此外,含有 Cu 提取物的传统中药(天花粉和苦瓜叶)也被证明能抑制 TrkA 和 Akt 的磷酸化。这些数据揭示了 Cus 抗瘙痒生物活性的部分机制。

结论

总之,随着最近发现 TrkA 作为治疗靶点的重要作用,Cus 可能成为设计改良 TrkA 激酶抑制剂的基础,这可能有朝一日有助于治疗瘙痒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/79b463d5a1ba/12906_2019_2709_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/3d2bfa37f248/12906_2019_2709_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/1b051d848f5f/12906_2019_2709_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/4a4b905b45a0/12906_2019_2709_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/79b463d5a1ba/12906_2019_2709_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/3d2bfa37f248/12906_2019_2709_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/1b051d848f5f/12906_2019_2709_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/4a4b905b45a0/12906_2019_2709_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/610e/6836411/79b463d5a1ba/12906_2019_2709_Fig4_HTML.jpg

相似文献

1
Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a.鉴定和表征葫芦素,一种新型小分子肌球蛋白受体激酶 a 抑制剂。
BMC Complement Altern Med. 2019 Nov 6;19(1):295. doi: 10.1186/s12906-019-2709-z.
2
Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity.具有 NGF 模拟活性的低分子量、非肽类 TrkA 受体激动剂。
Cell Death Dis. 2012 Sep 6;3(9):e389. doi: 10.1038/cddis.2012.129.
3
Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity.具有 NGF 模拟活性的低分子量、非肽类 TrkA 受体激动剂。
Cell Death Dis. 2012 Jul 5;3(7):e339. doi: 10.1038/cddis.2012.80.
4
NGF activates the phosphorylation of MAP1B by GSK3beta through the TrkA receptor and not the p75(NTR) receptor.神经生长因子(NGF)通过TrkA受体而非p75(NTR)受体,激活糖原合成酶激酶3β(GSK3β)介导的微管相关蛋白1B(MAP1B)磷酸化。
J Neurochem. 2003 Nov;87(4):935-46. doi: 10.1046/j.1471-4159.2003.02062.x.
5
Effect of synthetic cell-penetrating peptides on TrkA activity in PC12 cells.合成细胞穿透肽对PC12细胞中TrkA活性的影响。
J Pharmacol Sci. 2008 Jan;106(1):107-13. doi: 10.1254/jphs.fpz070263. Epub 2008 Jan 11.
6
Amyloid β-abrogated TrkA ubiquitination in PC12 cells analogous to Alzheimer's disease.在类似于阿尔茨海默病的PC12细胞中,淀粉样β蛋白消除了TrkA的泛素化。
J Neurochem. 2015 Jun;133(6):919-25. doi: 10.1111/jnc.13076. Epub 2015 Mar 19.
7
Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.抑制Abl酪氨酸激酶可通过改变信号复合物和受体周转来增强神经生长因子介导的Bcr-Abl转化细胞中的信号传导。
Oncogene. 2008 Aug 7;27(34):4678-89. doi: 10.1038/onc.2008.107. Epub 2008 Apr 21.
8
Methylmercury decreases NGF-induced TrkA autophosphorylation and neurite outgrowth in PC12 cells.甲基汞降低了神经生长因子(NGF)诱导的PC12细胞中TrkA的自磷酸化及神经突生长。
Brain Res Dev Brain Res. 2003 Mar 14;141(1-2):71-81. doi: 10.1016/s0165-3806(02)00644-2.
9
Growth arrest of PC12 cells by nerve growth factor is dependent on the phosphatidylinositol 3-kinase/Akt pathway via p75 neurotrophin receptor.神经生长因子介导的PC12细胞生长停滞通过p75神经营养因子受体依赖磷脂酰肌醇3激酶/蛋白激酶B信号通路。
J Neurosci Res. 2003 Apr 15;72(2):211-7. doi: 10.1002/jnr.10564.
10
Structural characterization of nonactive site, TrkA-selective kinase inhibitors.非活性位点TrkA选择性激酶抑制剂的结构表征
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E297-E306. doi: 10.1073/pnas.1611577114. Epub 2016 Dec 30.

引用本文的文献

1
Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities.葫芦素 B 及其衍生物:生物活性研究进展综述。
Molecules. 2024 Sep 4;29(17):4193. doi: 10.3390/molecules29174193.
2
Emerging Therapeutic Options for Chronic Pruritus.慢性瘙痒的新兴治疗选择
Am J Clin Dermatol. 2020 Oct;21(5):601-618. doi: 10.1007/s40257-020-00534-y.

本文引用的文献

1
Non-kinase targets of protein kinase inhibitors.蛋白激酶抑制剂的非激酶靶点。
Nat Rev Drug Discov. 2017 Jun;16(6):424-440. doi: 10.1038/nrd.2016.266. Epub 2017 Mar 10.
2
Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.基于中药成分的某些蛋白激酶抑制剂的研发
Front Pharmacol. 2017 Jan 9;7:523. doi: 10.3389/fphar.2016.00523. eCollection 2016.
3
Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.葫芦素D在宫颈癌中表现出强大的抗癌活性。
Sci Rep. 2016 Nov 8;6:36594. doi: 10.1038/srep36594.
4
Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture).青蒿素——中医药献给世界的礼物(诺贝尔奖演讲)。
Angew Chem Int Ed Engl. 2016 Aug 22;55(35):10210-26. doi: 10.1002/anie.201601967. Epub 2016 Aug 4.
5
Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways.葫芦素B通过调节多种细胞途径在体外和体内对人多发性骨髓瘤细胞发挥抗癌活性。
Oncotarget. 2017 Jan 24;8(4):5800-5813. doi: 10.18632/oncotarget.10584.
6
A New Golden Age of Natural Products Drug Discovery.天然产物药物发现的新黄金时代。
Cell. 2015 Dec 3;163(6):1297-300. doi: 10.1016/j.cell.2015.11.031.
7
A High-Throughput Radiometric Kinase Assay.一种高通量放射性激酶测定法。
Methods Mol Biol. 2016;1360:87-95. doi: 10.1007/978-1-4939-3073-9_7.
8
Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors.发现娃儿藤二酮作为TrkA激酶抑制剂的新型模板。
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5186-9. doi: 10.1016/j.bmcl.2015.09.070. Epub 2015 Sep 30.
9
Cucurbitacins - An insight into medicinal leads from nature.葫芦素——对天然药用先导物的洞察。
Pharmacogn Rev. 2015 Jan-Jun;9(17):12-8. doi: 10.4103/0973-7847.156314.
10
Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.局部TrkA激酶抑制剂CT327是治疗银屑病瘙痒的一种有效新型疗法:实验研究结果以及CT327在银屑病患者2b期临床试验中的疗效与安全性
Acta Derm Venereol. 2015 May;95(5):542-8. doi: 10.2340/00015555-2047.